Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
Phase 2 Unknown
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
Phase 2 Unknown
57 enrolled
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
Phase 1 Unknown
30 enrolled
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
Phase 1/2 Unknown
50 enrolled
Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
Phase 2 Unknown
54 enrolled
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 3 Unknown
312 enrolled
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Unknown
900 enrolled
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
Phase 2 Unknown
26 enrolled
Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
Phase 2 Unknown
150 enrolled
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
Phase 2 Unknown
41 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Phase 2 Unknown
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery
Phase 2 Unknown
20 enrolled
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 1/2 Unknown
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
Phase 3 Unknown
280 enrolled
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
Unknown
800 enrolled
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
Phase 3 Unknown
900 enrolled
Increasing Colorectal Cancer Screening in African Americans
Phase 3 Unknown
896 enrolled
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
Phase NA Unknown
1,000 enrolled
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Phase 3 Unknown
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
Phase 3 Unknown
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
Phase 3 Unknown
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
Phase 2 Unknown
Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Phase 2 Unknown
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
Phase NA Unknown
Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer
Phase 3 Unknown
774 enrolled
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
Phase 3 Unknown
1,050 enrolled
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
Phase 3 Unknown
200 enrolled
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Unknown
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Phase 1 Unknown
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
Phase 3 Unknown
300 enrolled
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
Phase 3 Unknown
336 enrolled
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
Phase NA Unknown
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
Phase 2 Unknown
50 enrolled
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
Phase 2 Unknown
70 enrolled
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
Phase 2 Unknown
47 enrolled
Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
Phase 2 Unknown
30 enrolled
Erlotinib in Treating Patients With Barrett Esophagus
Phase 1 Unknown
25 enrolled
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2 Unknown
225 enrolled
Screening to Predict Weight Loss in Patients With Cancer
Phase NA Unknown
220 enrolled
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Phase 1 Unknown
9 enrolled
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
46 enrolled
J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the Tumor
Phase NA Unknown
600 enrolled
Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer
Phase 3 Unknown
800 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled